Cited by 289Thyroid Cancer Diagnosis and TreatmentCancer survivorship and careThyroid and Parathyroid Surgery

Quality-of-Life Changes in Patients with Thyroid Cancer After Withdrawal of Thyroid Hormone Therapy

Open access
DOW, KAREN HASSEY, FERRELL, BETTY R., ANELLO, CAROL·1997·Thyroid

Abstract

Quality of life (QOL) is an important consideration as patients survive longer with cancer and is an area of increasing interest in patients with thyroid cancer who undergo long-term cancer surveillance. However, there are few disease-specific QOL tools available to evaluate QOL in patients with thyroid cancer. The purposes of this longitudinal, repeated-measures study were to: (1) test a new instrument, the QOL-Thyroid Scale, during thyroid hormone withdrawal; and (2) to evaluate the impact of thyroid hormone withdrawal on patients' perceived changes in quality of life. The sample included 34 subjects (mean age 40 years) undergoing thyroid hormone withdrawal in preparation for scanning procedures. Subjects completed three instruments (demographic data tool, the QOL-Thyroid, and the FACT-G) at four specific time points in relationship to scanning. The results demonstrated that the QOL-Thyroid tool is a reliable and valid measure of QOL. Cronbach's alpha coefficient of r = .78 between QOL-Thyroid and FACT-G indicated good concurrent validity. Second, the impact of thyroid hormone withdrawal on QOL showed significant changes in physical, psychological, and social well-being across the four testing points. The greatest changes occurred between peak hormone withdrawal and thyroxine (T4) therapy. While it is generally known that patients suffer troublesome physical symptoms relating to thyroid hormone withdrawal, the negative psychological, family, and work sequelae are less apparent. In conclusion, the QOL-Thyroid is a reliable and valid measure for use in evaluating patients undergoing scanning procedures and may be used to identify and target teaching and support for high-risk areas in patients lives that are negatively affected by hormone withdrawal.

Integrity signals

Registry

Crossref · 10.1089/thy.1997.7.613

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Withdrawal of LT4 or LT3 leads to recurrence of hypothyroidism in patients who had thyroid surgery for thyroid cancer or were diagnosed with profound hypothyroidism.

    “Although there are no randomized clinical trials comparing LT4 to placebo to treat hypothyroidism, it has clearly been demonstrated that LT4 or LT3 withdrawal leads to a recurrence of hypothyroidism in patients who have undergone thyroid surgery for thyroid cancer or who were diagnosed with profound hypothyroidism (44-46).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
DOW, K. H., FERRELL, B. R., & ANELLO, C.
Affiliations
University of Central Florida (US)
Venue
Thyroid
Published
1997-08
Volume
7
Issue
4
Pages
613-619
ISSN
  • 1050-7256 (ISSN-L)
  • 1557-9077
OpenAlex
W1993041398
Cited by
289
References
14
Citations by year
2026: 4 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 9 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 10 · 2016: 14 · 2015: 17 · 2014: 10 · 2013: 6 · 2012: 13
FWCI
2.62
Type
journal article
Language
en
Open access
Locations
  • Thyroid (publishedVersion)
  • PubMed (publishedVersion)
  • Journal of International Crisis and Risk Communication Research (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
Keywords
thyroid cancer, quality of life, thyroid hormone withdrawal, thyroxine therapy, cancer surveillance, thyroid imaging, FACT-G, psychometric validation
MeSH terms
Adult, Aged, Emotions, Female, Humans, Longitudinal Studies, Male, Middle Aged, Quality of Life, Thyroid Neoplasms, Thyroxine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review